Amidst the wave of globalization, the healthcare industry is undergoing unprecedented changes. As an important “weather vane” for the global medical industry, the CMEF International Exhibition provides a platform for global medical companies to showcase innovation, exchange and cooperation, and expand the market, helping enterprises to be more widely understood and recognized on a global scale.
As a new force in the field of domestically produced endoscopes, Jinhai Medical (02225) showcased its all-in-one 4K medical camera system and 4K 3D fluorescence endoscopic camera system. It is worth mentioning that at this year's CMEF Spring Exhibition, Jinhai Medical only showed the outside world that AI can only use endoscopic camera systems. In just half a year, the company's products have been further enriched, and it is easy to see that its R&D strength is strong.
Strong R&D strength, increasingly rich pipelines
According to the Zhitong Finance App, thanks to its excellent R&D capabilities, Jinhai Medical has achieved remarkable results in the field of high-end endoscopy. The company's product line covers 4K ultra-high-definition endoscopy systems, 3D and naked-eye 3D image processing systems, 4K fluorescence and multi-spectral ultra-high definition endoscopy systems, etc. These technologies are essential to improve the accuracy and safety of minimally invasive surgery.
As for the Endonext series true 4K 3D 4CMOS ultra-high-definition fluorescence endoscope system launched by Jinhai Medical, its true 4K screen has 8K pixel clarity and BT2020 ultra-wide color gamut, high color reproduction and resolution, and can present rich tissue textures in high definition to help doctors observe and locate surgical lesions and surrounding tissues; the master image algorithm is equipped with a new PAD wireless control system to achieve a very realistic 3D effect. The image is lossless and frameless, and various functions respond quickly to different surgical scenarios.
In addition, this product is equipped with the world's first AI voice control function, and has intelligent wake-up and multi-function one-button (sound) switching functions, making operation easier and safer and more efficient in actual application.
It is worth mentioning that Jinhai Medical's 4K3D naked eye fluorescence endoscope camera system obtained the first 4K3D fluorescence endoscope registration certificate in China. Furthermore, the registration certificate obtained is a Class II medical device license issued by the Shanghai Drug Administration. The Shanghai Administration's review is famous all over the country for its professionalism and rigor. After marketing, it is expected to establish an excellent production system and product quality, and take the lead in seizing market share.
In addition, based on its deep accumulation in the field of endoscopy technology, Jinhai Medical has entered the field of intervertebral foramen and minimally invasive spine, with a view to diversifying products and applications in the field of endoscopy, enriching product lines and application departments, and providing patients with better treatment plans.
In terms of technical reserves, Jinhai Medical currently has more than 60 patents, more than 20 trademarks, and more than 30 research projects. In the “minimally invasive 4.0 era,” Jinhai Medical's basic technology is fully advanced. The technologies it already has include three/four chips, naked eye 3D, 4K, 3D, and fluorescence. At a time when AI is rapidly developing, Jinhai Medical is also actively promoting R&D technology towards “minimally invasive 5.0.” In the future, the company will focus on molecular probes, multi-spectral, intelligent navigation, AI, AR enhancement, and infrared.
The exhibition is not only an important window for Jinhai Medical to showcase its R&D capabilities, but also provides the company with an opportunity to strengthen exchanges with peers in the industry, and helps establish new business contacts and promote the marketing of future products.
Appoint senior veterans to lead sales and prepare 4 sales centers to raise the level of commercialization
Medical devices are also a very “cautious” and “conservative” industry. Many medical device products are directly related to saving lives. Healthcare workers are very “cautious” about industry innovation, and the promotion of innovative products often requires large communication costs. This requires medical device companies to have a full understanding of healthcare workers and medical scenarios.
Therefore, sales of medical devices are very different from ordinary sales. High-value medical equipment requires very professional clinical training, installation, and commissioning at local hospitals at the time of delivery, which is a very important factor in ensuring quality.
In terms of commercialization, Jinhai Medical recently appointed He Xiao, a veteran with more than 10 years of medical sales experience, as chief marketing officer to develop and implement the company's marketing strategies, sales targets, and sales channel promotion and management. Relying on its rich networking resources in the medical industry, the pace of commercialization of Jinhai Medical is expected to accelerate. Furthermore, in order to better serve customers, Jinhai Medical plans to build 4 sales centers.
It is worth mentioning that after more than 40 years, CMEF has gathered rich high-quality international resources, established a strong international brand influence, and has become the preferred platform for many high-quality companies to go overseas. Therefore, participating in the CMEF exhibition is expected to further enhance the commercialization level of Jinhai Healthcare.
According to the organizer, the degree of internationalization of CMEF continues to increase, compounded by Shenzhen's favorable visa-free transit policy, providing more convenience for inviting international customers. At present, the number of pre-registered international visitors has doubled over the same period last year, attracting international professional visitors from more than 150 countries and regions around the world. The CMEF exhibition will become a high-quality “incubator” for global trade.
It is worth noting that at this exhibition, Sinopharm Reed Exhibitions signed a cooperation agreement with the Malaysian Association of Private Hospitals (APHM). Next year, Sinopharm Reed Exhibitions's Health Industry Exhibition Series (ASEAN) will cooperate with the APHM International Healthcare Conference and Exhibition hosted by the Malaysian Private Hospital Association to move the Chinese medical device company exhibition to Malaysia for the first time, promoting more Chinese medical device products to overseas markets.
Currently, Jinhai Medical is seeking to form strategic alliances with large pharmaceutical supply chain companies such as Sinopharm Reed Exhibitions, etc., with the aim of achieving mutual benefit and win-win results through resource sharing. If a strategic cooperation is reached with Sinopharm Reed Exhibitions, there is no doubt that Jinhai Medical's products will be quickly realized.
Overall, as new products continue to move from laboratory to clinical application, Jinhai Medical is gradually consolidating its leading position in the domestic high-end medical device market, especially in the rapidly developing field of endoscopy. Along with continuous R&D investment and commercialization efforts, Jinhai Medical is steadily moving towards the goal of becoming an important player in the domestic and international markets, and has shown a leading position in the field of high-end medical equipment, especially endoscopy technology.
Looking forward to the future, Jinhai Medical will develop more accurate and effective marketing plans based on its professional technical background. Relying on star products such as 4K 3D fluorescence endoscopes, and the support of current favorable policy environments and industry trends, Jinhai Healthcare has shown great potential for development.